Education
About Us
Working with TipRanks
Follow Us
Vital KSK Holdings, Inc. (JP:3151)
:3151
3151 Stock Chart & Stats
¥1370.00
-¥1.00(-0.08%)
At close: 4:00 PM EST
¥1370.00
-¥1.00(-0.08%)
Day’s Range― - ―
52-Week Range¥1,102.00 - ¥1,503.00
Previous CloseN/A
Volume69.00K
Average Volume (3M)121.33K
Market Cap
¥64.84B
Enterprise Value¥41.34B
Total Cash (Recent Filing)¥24.39B
Total Debt (Recent Filing)¥6.51B
Price to Earnings (P/E)18.0
Beta0.46
Next Earnings
May 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.22%
Share Statistics
EPS (TTM)19.01
Shares Outstanding51,902,977
10 Day Avg. Volume69,970
30 Day Avg. Volume121,326
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.58
Price to Sales (P/S)0.10
P/FCF Ratio-5.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseVery low debt (D/E 0.08) and a 35.36% equity ratio give the company durable financial flexibility. This capital structure allows Vital KSK to fund operations or strategic investments without relying on heavy external financing, and to better withstand sector downturns over months.
Consistent Revenue GrowthA steady top-line increase (2.18% YoY) signals persistent demand in its medical distribution markets. Reliable revenue growth provides a platform for scale, helps absorb fixed costs, and supports strategic initiatives to improve margins and cash conversion over a multi-month horizon.
Improving Profitability MarginsImprovement in net margin to 1.22% alongside an 8.20% gross margin indicates management progress on profitability. If sustained, this margin recovery can materially improve cash generation and reinvestment capacity, supporting longer-term operational stability and shareholder returns.
Bears Say
Negative Operating Cash FlowPersistent negative operating and free cash flow, with an OCFO-to-net-income ratio of -1.10, shows the company struggles to convert accounting profits into cash. This undermines liquidity, raises reliance on financing despite low leverage, and limits capital for capex, working capital, or dividends over the medium term.
Low Operating EfficiencyAn EBIT margin below 1% reflects weak operating efficiency in distribution operations. Such thin operating profits leave little buffer for cost inflation or competitive pressure, constrain reinvestment in the business, and make sustained margin improvement imperative for long-term resilience.
Moderate ROE / Asset ReturnsA 6.90% ROE signals only moderate returns on shareholder capital, implying suboptimal asset utilization or capital allocation. Over time, this limits value creation for investors unless the company increases margins, improves turnover, or reallocates capital to higher-return opportunities.
Vital KSK Holdings, Inc. News
3151 FAQ
What was Vital KSK Holdings, Inc.’s price range in the past 12 months?
Vital KSK Holdings, Inc. lowest stock price was ¥1102.00 and its highest was ¥1503.00 in the past 12 months.
What is Vital KSK Holdings, Inc.’s market cap?
Vital KSK Holdings, Inc.’s market cap is ¥64.84B.
When is Vital KSK Holdings, Inc.’s upcoming earnings report date?
Vital KSK Holdings, Inc.’s upcoming earnings report date is May 19, 2026 which is in 72 days.
How were Vital KSK Holdings, Inc.’s earnings last quarter?
Vital KSK Holdings, Inc. released its earnings results on Feb 10, 2026. The company reported ¥19.01 earnings per share for the quarter, beating the consensus estimate of N/A by ¥19.01.
Is Vital KSK Holdings, Inc. overvalued?
According to Wall Street analysts Vital KSK Holdings, Inc.’s price is currently Overvalued.
Does Vital KSK Holdings, Inc. pay dividends?
Vital KSK Holdings, Inc. pays a Semiannually dividend of ¥34 which represents an annual dividend yield of 4.22%. See more information on Vital KSK Holdings, Inc. dividends here
What is Vital KSK Holdings, Inc.’s EPS estimate?
Vital KSK Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vital KSK Holdings, Inc. have?
Vital KSK Holdings, Inc. has 51,902,977 shares outstanding.
What happened to Vital KSK Holdings, Inc.’s price movement after its last earnings report?
Vital KSK Holdings, Inc. reported an EPS of ¥19.01 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.276%.
Which hedge fund is a major shareholder of Vital KSK Holdings, Inc.?
Currently, no hedge funds are holding shares in JP:3151
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vital KSK Holdings, Inc.
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Technical Analysis
OLBA HEALTHCARE HOLDINGS, Inc.
―
Ohki Health Care Holdings, Inc.
―
Charm Care Corporation
―
Amvis Holdings.Inc.
―
YAMASHITA HEALTH CARE HOLDINGS, INC.
―
Options Prices
Currently, No data available
---